E Fund Management’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,642
| Closed | -$54.7K | – | 364 |
|
|
2024
Q2 | $54.7K | Buy |
+15,642
| New | +$54.7K | ﹤0.01% | 316 |
|
|
2022
Q4 | – | Sell |
-41,391
| Closed | -$175K | – | 343 |
|
|
2022
Q3 | $175K | Sell |
41,391
-45,190
| -52% | -$191K | 0.02% | 314 |
|
|
2022
Q2 | $242K | Buy |
86,581
+38,818
| +81% | +$108K | 0.02% | 264 |
|
|
2022
Q1 | $273K | Buy |
47,763
+29,396
| +160% | +$168K | 0.01% | 229 |
|
|
2021
Q4 | $168K | Buy |
18,367
+3,562
| +24% | +$32.6K | 0.01% | 275 |
|
|
2021
Q3 | $158K | Buy |
+14,805
| New | +$158K | 0.01% | 244 |
|